Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary F Lewis

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Diabetes|October 8, 2014
Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrationsSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 12, 2019
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct MechanismsPriska Stahel, Changting Xiao, Xenia Davis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?Satya Dash, Changting Xiao, Cecilia Morgantini, et al.
Diabetes|March 11, 2015
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in HumansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 2, 2022
Enteral glucose, absorbed and metabolized, potently enhances mesenteric lymph flow in chow- and high-fat-fed ratsLili Tian, Majid Mufaqam Syed-Abdul, Priska Stahel, et al.
The Journal of Endocrinology|August 11, 2006
Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathwayVictor Wong, Linda Szeto, Kristine Uffelman, et al.
The Lancet. Diabetes & Endocrinology|March 27, 2025
Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitisMajid M Syed-Abdul, Lili Tian, Robert A Hegele, et al.
Diabetes|December 24, 2009
Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acidsMirjana Pavlic, Changting Xiao, Linda Szeto, et al.
Diabetes|June 23, 2016
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL CholesterolChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|October 29, 2010
Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humansChangting Xiao, Mirjana Pavlic, Linda Szeto, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Diabetes|October 8, 2014
Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrationsSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 12, 2019
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct MechanismsPriska Stahel, Changting Xiao, Xenia Davis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?Satya Dash, Changting Xiao, Cecilia Morgantini, et al.
Diabetes|March 11, 2015
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in HumansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 2, 2022
Enteral glucose, absorbed and metabolized, potently enhances mesenteric lymph flow in chow- and high-fat-fed ratsLili Tian, Majid Mufaqam Syed-Abdul, Priska Stahel, et al.
The Journal of Endocrinology|August 11, 2006
Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathwayVictor Wong, Linda Szeto, Kristine Uffelman, et al.
The Lancet. Diabetes & Endocrinology|March 27, 2025
Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitisMajid M Syed-Abdul, Lili Tian, Robert A Hegele, et al.
Diabetes|December 24, 2009
Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acidsMirjana Pavlic, Changting Xiao, Linda Szeto, et al.
Diabetes|June 23, 2016
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL CholesterolChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|October 29, 2010
Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humansChangting Xiao, Mirjana Pavlic, Linda Szeto, et al.
Pageof 14